Stocks
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
CHICAGO, July 02, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 770,000 shares of its common stock in the open market at an average price of approximately $0.1956 per share, extending the buyback activity it began this week. The Company has now repurchased a total of 3,420,000 shares for approximately $650,000 under its previously ann
About this update from Cosmos Health Inc.
CHICAGO, July 02, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 770,000 shares of its common stock in the open market at an average price of approximately $0.1956 per share, extending the buyback activity it began this week. The Company has now repurchased a total of 3,420,000 shares for approximately $650,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may buy back shares from time to time in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rules 10b5-1 and 10b-18 and other applicable restrictions. The Company intends to continue making open market purchases, subject to market conditions, under the program, which expires on December 31, 2026, and may be renewed at the Company's sole discretion. Greg Siokas, CEO of Cosmos Health, stated: "The steady expansion of our repurchase activity reflects how compelling we find today's share price relative to the intrinsic value of our diversified global platform. We view repurchasing our stock as an attractive use of capital on behalf of our shareholders, and we intend to keep acting on that conviction." About Cosmos Health Inc.Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and foc...
View stock analysis, news, and events for Cosmos Health Inc.